Update COVID-19 Malang
Jajak Pendapat

Apa saja gejala COVID-19?

Batuk
Pilek
Sakit Tenggorok
Sesak/Nyeri dada
Semua

Klinik Respirasi Malang Klinik Respirasi Malang Whatsapp Klinik Respirasi Malang Reservasi Klinik Respirasi malang Peta Lokasi Klinik
Berita Kesehatan

Aberrant anti-viral response of Natural Killer cell in severe asthma


Justine Devulder, Cécile Chenivesse, Valérie Ledroit, Stéphanie Fry, Pierre-Emmanuel Lobert, Didier Hober, Anne Tsicopoulos, Catherine Duez

European Respiratory Journal 2020; DOI: 10.1183/13993003.02422-2018

Abstract

Rhinovirus infections are the main cause of asthma exacerbations. As Natural Killer (NK) cells are important actors of the antiviral innate response, we aimed at evaluating the functions of NK cells from severe asthma patients in response to rhinovirus-like molecules or rhinoviruses. Peripheral blood mononuclear cells from patients with severe asthma and healthy donors were stimulated with pathogen-like molecules or with the rhinoviruses (RV)-A9 and RV-2. NK cell activation, degranulation and IFN-γ expression were analysed. NK cells from severe asthma patients were less cytotoxic than those from healthy donors in response to TLR3, TLR7/8 or RV-A9 but not in response to RV-2 stimulation. Furthermore, when cultured with IL-12+IL-15, cytokines which are produced during viral infections, NK cells from patients with severe asthma were less cytotoxic and expressed less IFN-γ than NK cells from healthy donors. NK cells from severe asthmatics exhibited an exhausted phenotype, with an increased expression of the checkpoint molecule Tim-3. Together, our findings indicate that the activation of NK cells from patients with severe asthma may be insufficient during some but not all respiratory infections. The exhausted phenotype may participate in NK cell impairment and aggravation of viral-induced asthma exacerbation in these patients.

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Dr DEVULDER reports In addition, Dr DEVULDER has a patent EP18306287.6 issued to INSERM.

Conflict of interest: Dr CHENIVESSE reports In addition, Dr CHENIVESSE has a patent EP18306287.6 issued to INSERM.

Conflict of interest: Dr LEDROIT has nothing to disclose.

Conflict of interest: Dr FRY has nothing to disclose.

Conflict of interest: Dr LOBERT has nothing to disclose.

Conflict of interest: Dr HOBER has nothing to disclose.

Conflict of interest: Dr TSICOPOULOS has nothing to disclose.

Conflict of interest: Dr DUEZ reports In addition, Dr DUEZ has a patent EP18306287.6 issued to INSERM.

  • Received December 26, 2018.
  • Accepted February 3, 2020.
  • Copyright ©ERS 2020

sumber : https://erj.ersjournals.com/content/early/2020/02/06/13993003.02422-2018

 
 

PRAKTEK Alamat 1:
RS Panti Waluya /RKZ Sawahan, Lt II-N
, Dr Koentjahja, SpP
Nusakambangan 56, Malang 65117
08113777488 / 362017 ext. 88.23
Pukul 18.00 - selesai, kec. Sabtu / Libur

Alamat 2:
RS Lavalette
, Dr Koentjahja, SpP
WR Supratman 10, Malang 65111
08133175788
Selasa & Kamis, Pukul 17.00 - 18.00

    
RUMAHWilis Indah A-6, Malang 65115
0341-568711


Peta Lokasi